← Leaderboards
Akshay Sharma
St. Jude Children'S Research Hospital
$1,236,780
Attributed
$3,710,340
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,710,340 · 1
By mechanism
U01$3,710,340 · 1
Top collaborators
- Shengdar Tsai4 shared
- Mitchell J Weiss4 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Jian Xu$9,499,630
- Phillip A Doerfler$1,035,814
- James R Downing$3,840,185
- Derek A Persons$6,676,571
- Michael A Dyer$24,988,379
Others in their field
Other Rising Stars on “Adult”
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- April Carson · University Of Mississippi Med Ctr$9,022,104
- Christine W Hockett · Avera Mckennan$8,908,366
Research focus
AdultAffectAllogenicAmd3100AmericanAnalytical MethodAttentionAutologousBcl11a GeneBench To BedsideBeta GlobinBindingBioethics ConsultantsBiological MarkersBiophysical PropertiesBirthBloodBone MarrowCaringCd34 GeneCell Differentiation ProcessCellsCessation Of LifeAcute Pain
Grant awards (4)
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease$1,183,000
U01 · FY2025 · HL
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease$185,000
U01 · FY2025 · HL
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease$1,159,340
U01 · FY2024 · HL
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell disease$1,183,000
U01 · FY2023 · HL